HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Pakistan

Pakistan: HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate was 26.23 % change on previous year in 2024. ◆ Volatile

Latest (2024)
26.23 % change on previous year
Change on year
down 23.1%
World rank
3rd
of 157 countries
All-time high
965.92 % change on previous year
in 2002
All-time low
-17.11 % change on previous year
in 2001
Years of data
24
2001–2024

HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Pakistan, 2001–2024

02004006008001.0k2001201220242001: -17.1 % change on previous year2002: 965.9 % change on previous year2003: 417.7 % change on previous year2004: 104.2 % change on previous year2005: 57.8 % change on previous year2006: 22.5 % change on previous year2007: 136.3 % change on previous year2008: 133.7 % change on previous year2009: 59.5 % change on previous year2010: 37.2 % change on previous year2011: 9.3 % change on previous year2012: 14.9 % change on previous year2013: 20 % change on previous year2014: 15.6 % change on previous year2015: 28.9 % change on previous year2016: 27.6 % change on previous year2017: 36.6 % change on previous year2018: 30.9 % change on previous year2019: 32 % change on previous year2020: 14.1 % change on previous year2021: -1.3 % change on previous year2022: 20.3 % change on previous year2023: 34.1 % change on previous year2024: 26.2 % change on previous year

Source: Statizoid (derived). Measured in % change on previous year.

Analysis

In 2024, hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Pakistan stood at 26.23 % change on previous year.

That represents a change of down 23.1% on the previous year and up 67.9% over ten years.

Over the whole period, hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Pakistan peaked at 965.92 % change on previous year in 2002 and was at its lowest, -17.11 % change on previous year, in 2001.

Pakistan ranks 3rd of 157 countries on this measure, in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Pakistan, year by year

Annual values for HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Pakistan, 2001 to 2024.
Year % change on previous year Change
2001 -17.11 % change on previous year
2002 965.92 % change on previous year -5745.4%
2003 417.69 % change on previous year -56.8%
2004 104.21 % change on previous year -75.1%
2005 57.78 % change on previous year -44.6%
2006 22.46 % change on previous year -61.1%
2007 136.25 % change on previous year +506.6%
2008 133.66 % change on previous year -1.9%
2009 59.51 % change on previous year -55.5%
2010 37.2 % change on previous year -37.5%
2011 9.25 % change on previous year -75.1%
2012 14.92 % change on previous year +61.3%
2013 20.01 % change on previous year +34.1%
2014 15.62 % change on previous year -21.9%
2015 28.89 % change on previous year +84.9%
2016 27.57 % change on previous year -4.6%
2017 36.58 % change on previous year +32.7%
2018 30.88 % change on previous year -15.6%
2019 31.98 % change on previous year +3.6%
2020 14.07 % change on previous year -56.0%
2021 -1.31 % change on previous year -109.3%
2022 20.25 % change on previous year -1641.4%
2023 34.12 % change on previous year +68.5%
2024 26.23 % change on previous year -23.1%

Pakistan compared with similar countries

  • Pakistan's 26.23 % change on previous year is above the median for lower middle income countries, which is 0.8262 % change on previous year, 31.7× the median. (42 countries reporting)
  • Pakistan's 26.23 % change on previous year is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 8.88 % change on previous year, 3.0× the median. (22 countries reporting)

Biggest year-on-year movements

Years where HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Pakistan changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2002 +5745.4% -17.11 % change on previous year 965.92 % change on previous year
2022 +1641.4% -1.31 % change on previous year 20.25 % change on previous year
2007 +506.6% 22.46 % change on previous year 136.25 % change on previous year

Averages by decade

DecadeAverage LowestHighest Years
2000s 208.93 % change on previous year -17.11 % change on previous year 965.92 % change on previous year 9
2010s 25.29 % change on previous year 9.25 % change on previous year 37.2 % change on previous year 10
2020s 18.67 % change on previous year -1.31 % change on previous year 34.12 % change on previous year 5

Countries ranked near Pakistan

  1. 1 Fiji 68.33 % change on previous year compare
  2. 2 Madagascar 34.12 % change on previous year compare
  3. 4 Libya 22.67 % change on previous year compare
  4. 5 Indonesia 22.61 % change on previous year compare
  5. 6 Afghanistan 22.35 % change on previous year compare

See the full ranking of 157 places →

More health data for Pakistan

All data for Pakistan →

Frequently asked questions

What is hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Pakistan?
Hiv/aids deaths averted by antiretroviral therapy, annual growth rate in Pakistan was 26.23 % change on previous year in 2024, according to Statizoid (derived).
What is the highest hiv/aids deaths averted by antiretroviral therapy, annual growth rate recorded in Pakistan?
The highest recorded value was 965.92 % change on previous year in 2002.
What is the lowest hiv/aids deaths averted by antiretroviral therapy, annual growth rate recorded in Pakistan?
The lowest recorded value was -17.11 % change on previous year in 2001.
How does Pakistan rank for hiv/aids deaths averted by antiretroviral therapy, annual growth rate?
Pakistan ranks 3rd out of 157 countries with data for 2024.
Is hiv/aids deaths averted by antiretroviral therapy, annual growth rate rising or falling in Pakistan?
Over the last ten years it is up 67.9%. The long-run trend across the full record is volatile.
Where does this Pakistan data come from?
The figures come from Statizoid (derived), published as part of HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under Derived by Statizoid from the sources named on the page.

Share, cite or embed this page

Cite this page

HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Pakistan. Statizoid, drawing on Statizoid (derived). Retrieved 13 September 2026, from https://health.statizoid.com/stat/hiv-aids-deaths-averted-by-antiretroviral-therapy-annual-growth-rate/pakistan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under Derived by Statizoid from the sources named on the page; please keep the attribution.

<a href="https://health.statizoid.com/stat/hiv-aids-deaths-averted-by-antiretroviral-therapy-annual-growth-rate/pakistan/">HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate in Pakistan</a> — Statizoid

How this figure is calculated

The year-on-year percentage change in HIV/AIDS deaths averted by antiretroviral therapy. Computed from consecutive annual observations; years either side of a gap are skipped rather than bridged.

Computed from

Statizoid computes this series; the underlying measurements belong to the publishers named above. The arithmetic is applied to every country and year where both inputs report, and nothing is estimated unless the page says so.

About this data

Indicator
HIV/AIDS deaths averted by antiretroviral therapy, annual growth rate
Unit
% change on previous year
Source
Statizoid (derived)
Licence
Derived by Statizoid from the sources named on the page
Coverage
157 places, 3,585 data points, 1996–2024
Last refreshed

The year-on-year percentage change in HIV/AIDS deaths averted by antiretroviral therapy. Computed from consecutive annual observations; years either side of a gap are skipped rather than bridged.